# Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine

> **NCT03874715** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 210 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Insulin Aspart SAR341402
- **DRUG:** Insulin Aspart
- **DRUG:** Insulin glargine U100

## Key facts

- **NCT ID:** NCT03874715
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-11
- **Primary completion:** 2020-07-08
- **Final completion:** 2020-07-08
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03874715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03874715, "Comparison of SAR341402 to NovoLog in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03874715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*